Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6

INTRODUCTION: Multipotent stromal cells (MSCs) are currently in clinical trials for a number of inflammatory diseases. Recent studies have demonstrated the ability of MSCs to attenuate inflammation in rodent models of acute lung injury (ALI) suggesting that MSCs may also be beneficial in treating AL...

Descripción completa

Detalles Bibliográficos
Autores principales: Danchuk, Svitlana, Ylostalo, Joni H, Hossain, Fokhrul, Sorge, Randy, Ramsey, Austin, Bonvillain, Ryan W, Lasky, Joseph A, Bunnell, Bruce A, Welsh, David A, Prockop, Darwin J, Sullivan, Deborah E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218818/
https://www.ncbi.nlm.nih.gov/pubmed/21569482
http://dx.doi.org/10.1186/scrt68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218818/
https://www.ncbi.nlm.nih.gov/pubmed/21569482
http://dx.doi.org/10.1186/scrt68

Ejemplares similares